Ginkgo biloba for the treatment of vitilgo vulgaris: an open label pilot clinical trial.

ABSTRACT:

Background

Vitiligo is a common hypopigmentation disorder with significant psychological impact if occurring before adulthood. A pilot clinical trial to determine the feasibility of an RCT was conducted and is reported here.

Methods

12 participants 12 to 35 years old were recruited to a prospective open-label pilot trial and treated with 60 mg of standardized G. biloba two times per day for 12 weeks. The criteria for feasibility included successful recruitment, 75% or greater retention, effectiveness and lack of serious adverse reactions. Effectiveness was assessed using the Vitiligo Area Scoring Index (VASI) and the Vitiligo European Task Force (VETF), which are validated outcome measures evaluating the area and intensity of depigmentation of vitiligo lesions. Other outcome

SUBMITTER: Szczurko O 

PROVIDER: S-EPMC3065445 | biostudies-literature | 2011 Mar

REPOSITORIES: biostudies-literature